홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Dicyclohexylcarbodiimide → Tertiary butyl 7beta-(2-(2-tritylaminothiazol-4-yl)-2-((1-methylimidazol-5-yl)methoxyimino)acetamido)-3-acetoxymethyl-3-cephem-4-carboxylate

HRID 746323
인쇄

반응식

HRID 746323 반응식
[C:1]([NH:20][C:21]1[S:22][CH:23]=[C:24]([C:26](=[N:30][O:31][CH2:32][C:33]2[N:37]([CH3:38])[CH:36]=[N:35][CH:34]=2)[C:27](O)=[O:28])[N:25]=1)([C:14]1[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1)([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH2:39][C@@H:40]1[C:59](=[O:60])[N:42]2[C:43]([C:52]([O:54][C:55]([CH3:58])([CH3:57])[CH3:56])=[O:53])=[C:44]([CH2:47][O:48][C:49](=[O:51])[CH3:50])[CH2:45][S:46][C@H:41]12.ON1C2C=CC=CC=2N=N1.C1CCC(N=C=NC2CCCCC2)CC1>C(Cl)Cl>[C:1]([NH:20][C:21]1[S:22][CH:23]=[C:24]([C:26](=[N:30][O:31][CH2:32][C:33]2[N:37]([CH3:38])[CH:36]=[N:35][CH:34]=2)[C:27]([NH:39][C@@H:40]2[C:59](=[O:60])[N:42]3[C:43]([C:52]([O:54][C:55]([CH3:57])([CH3:56])[CH3:58])=[O:53])=[C:44]([CH2:47][O:48][C:49](=[O:51])[CH3:50])[CH2:45][S:46][C@H:41]23)=[O:28])[N:25]=1)([C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1)([C:14]1[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=1)[C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 10868DicyclohexylcarbodiimideHCID 757711-HydroxybenzotriazoleHCID 15573427tert-butyl (6R,7R)-3-[(acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateHCID 867409312-(2-Tritylaminothiazol-4-yl)-2-((1-methylimidazol-5-yl)methoxyimino)acetic acid

생성물 1

HCID 131714795
Tertiary butyl 7beta-(2-(2-tritylaminothiazol-4-yl)-2-((1-methylimidazol-5-yl)methoxyimino)acetamido)-3-acetoxymethyl-3-cephem-4-carboxylate
수율 77.9%

시약·촉매·용매 1

HCID 6344Dichloromethane용매2회

실험 절차

5.23 g of 2-(2-tritylaminothiazol-4-yl)-2-((1-methylimidazol-5-yl)methoxyimino)acetic acid and 3.28 g of tertiary butyl 7β-amino-3-acetoxymethyl-3-cephem-4-carboxylate were suspended in 200 ml of methylene chloride and 1.35 g of 1-hydroxybenzotriazole was added thereto. A mixture of 2.27 g of DCC and 20 ml of methylene chloride was added to the mixture under stirring and cooling in an ice-bath. The resulting mixture was stirred for 1 hour at the same temperature and then stirred for 23 hours at room temperature. The insoluble material was removed by filtration and the filtrate was concentrated to dryness in vacuo. The residue was purified by silica gel column chromatography with a 1% methanol-chloroform eluent to give 6.49 g of tertiary butyl 7β-(2-(2-tritylaminothiazol-4-yl)-2-((1-methylimidazol-5-yl)methoxyimino)acetamido)-3-acetoxymethyl-3-cephem-4-carboxylate (syn isomer) as a powder.

후처리

  1. additionwas added to the mixture
  2. temperaturecooling in an ice-bath
  3. stirringThe resulting mixture was stirred for 1 hour at the same temperature
  4. stirringstirred for 23 hours at room temperature
  5. customThe insoluble material was removed by filtration
  6. concentrationthe filtrate was concentrated to dryness in vacuo
  7. customThe residue was purified by silica gel column chromatography with a 1% methanol-chloroform eluent

출처 및 근거

ORD 기록
ord-1b4d1c63996f4aa1b9f3bbd0e51b6299
출처 데이터셋
uspto-grants-1986_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04603198

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트